Rezul News/10330498

Global Private Group has advised Biopharmaceutical Company on the raising of EUR 270 million through a placing of new shares

Global Private Group acted as reporting accountant on the fund raising, and sole arranger.

NEW YORK - May 2, 2017 - Rezul -- Global Private Group has advised Biopharmaceutical Company on the raising of EUR 270 million through a placing of new shares.

Global Private Group
acted as reporting accountant on the fund raising, and sole arranger.

The Biopharmaceutical Company is a life sciences company providing services and technologies enabling the development and manufacture of biopharmaceutical products. Since its admission the business has grown significantly organically and via acquisition in both the Europe and US.

The Biopharmaceutical Company intends to use the proceeds from the placing to acquire a Chemistry Research Solutions Company, a specialist contract chemistry and bio-conjugation company with operations in Europe and US, and to back further research and development work.

More on Rezul News
The Biopharmaceutical Company says: "We were very pleased with the way the Global Private Group's Corporate Finance team pragmatically managed this piece of work, complementing their audit team who were assisting with our half year results announced on the same day. Its tax team also provided advice on the process, the acquisition and ongoing actions."

The Head of Corporate Finance at Global Private Group adds: "We are delighted to have advised The Biopharmaceutical Company on its recent placing and wish them every success with the acquisition and its growing business presence."

Visit http://www.globalprivategroup.com for details.

Media Contact
Global Private Group
(888) 249-0213
(888) 249-0213
***@globalprivategroup.com


Source: Global Private Group

Show All News |

0 Comments

Latest on Rezul News